Navigation Links
Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
Date:10/20/2008

Ted Daley, President of Raptor's clinical division stated, "We are pleased that dosing is now underway in the Phase 2a clinical trial in NASH, a disease that may have a severe impact on the long-term health of a large number of people. Cysteamine represents an exciting potential treatment for NASH patients currently limited to diet and exercise for disease management. The NASH program is part of our strategy to leverage cysteamine's known safety profile and potential efficacy in several indications where it has already shown promise in clinical and preclinical studies."

Joel Lavine, M.D., Ph.D., pediatric gastroenterologist at UCSD and principal investigator for the NASH study, commented, "The initiation of patient dosing in the NASH trial offers the opportunity to evaluate a potential new treatment for this disorder. We're pleased to collaborate with Raptor for this study as we work to find a treatment for NASH."

NASH is believed to affect 2% to 5% of the U.S. population. While commonly diagnosed in insulin-resistant obese adults with diabetes and abnormal serum lipid profiles, NASH can also occur in children, elderly and non-diabetic persons of average weight. Though most people with NASH feel healthy and show no outward signs of liver disease, NASH causes decreased liver function and potentially leads to cirrhosis, liver failure and end-stage liver disease. In more severe cases, the progressive nature of NASH may require liver transplantation in affected patients.

About Cysteamine and DR Cysteamine

Cysteamine is cleared for market by the FDA and EMEA to treat cystinosis, a rare and genetic lysosomal storage disease. The drug's potential to accumulate in the liver may create a targeted treatment effect for patients with NASH. DR Cysteamine is designed as an enterically coated, oral formulation of cysteamine.

Raptor obtained an exclusive, worldwide license to DR Cysteamine, as well as orphan drug designation from the FDA for DR Cy
'/>"/>

SOURCE Raptor Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
2. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
3. Raptor Pharmaceuticals Provides Update of Product Programs
4. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
5. Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial
6. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
7. Access Pharmaceuticals Presents New Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
8. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
9. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
10. Critical Pharmaceuticals Enter Sustained Release hGH Arena
11. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Does your doctor ... nearly 800 doctors have recommended marijuana to the over 112,000 ... 20. But the majority of the other roughly 20,300+ active ... know very little about it – even though a poll ... adults say they have tried it. ...
(Date:8/29/2014)... , Aug. 29, 2014  United Therapeutics Corporation ... U.S. District Court for the District of ... in the company,s case against Sandoz, Inc. regarding United ... Peter Sheridan ruled that U.S. Patent No. 6,765,117 ... enjoined Sandoz from marketing its generic product until the ...
(Date:8/29/2014)... , August 29, 2014 ... by Product & Services (Equipment, Reagent, Primer, Probe, ... (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) ... the global Oligonucleotide Synthesis Market is expected to ... in 2014, growing at a CAGR of 9.8% ...
Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
(Date:9/1/2014)... Mass., (PRWEB) September 01, 2014 BCC ... BLOOD-BRAIN BARRIER TECHNOLOGIES AND GLOBAL MARKETS , ... $21.8 million in 2013 and is expected to reach ... grow to $471.5 million by 2019, which is equivalent ... through 2019. The receptor-mediated transport (RMT) segment is forecasted ...
(Date:9/1/2014)... 01, 2014 Registration is now open for ... and 1-Mile Race to be held on Sunday, September 21, ... Yard at Harmon Meadow in Secaucus, New Jersey. All proceeds ... national nonprofit dedicated to restoring a sense of self, restoring ... and our military families. , General registration is $30 with ...
(Date:9/1/2014)... 2014 The Outlier Series announced the ... interview content from one of the exceptional women featured ... Women Game Changers . The title of the upcoming ... Changer Jenny McClendon . McClendon is currently a full-time ... the star of WeTV show, Raising Sextuplets. , Jenny ...
(Date:9/1/2014)... Vegas, Nevada (PRWEB) September 01, 2014 ... host to over 3,000 medical professionals and 10,000 consumers ... Week is a 5-day gathering of the nation’s top ... its associated diseases or conditions. The week-long event contains ... relevant evidence-based scientific instruction available in the pain management ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 MYMOBILEUNI ... community utilizing social media marketing tools access to ... programs. MMU will utilize all tools to reach ... partner for our multiple learning channels. , MMU, ... app, and an authoring tool that applies social ...
Breaking Medicine News(10 mins):Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 2Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 3Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 3Health News:Medical Marijuana Doctor Company Set to Present at Las Vegas Pain Week 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 2Health News:My Mobile University Announces Global Strategic Plan and Unveils New Android App to Enhance and Impact Lives World-Wide Through Education for All as Learning Platform 3
... Don,t Disclose Depression to Their Physicians , Many adults ... of depression to their primary care physician. In a ... one or more reasons for not talking to a ... frequently cited reason being concern the physician would recommend ...
... to reduce federal health care spending in a socially ... letter to the Congressional Joint Committee on ... "On behalf of ACP,s 132,000 members, ACP ... framework to achieve hundreds of billions of dollars in ...
... , MONDAY, Sept. 12 (HealthDay News) -- Women with ... risk of developing breast and ovarian cancers, are being diagnosed ... ,We found with some mathematical modeling about a ... Jennifer Litton, a breast medical oncologist at the University of ...
... 12, 2011 The American Society for Gastrointestinal Endoscopy ... its program specifically dedicated to promoting quality in endoscopy, ... United States. The ASGE Endoscopy Unit Recognition Program honors ... quality assurance, endoscope reprocessing and CDC infection control guidelines. ...
... BVES butts heads with colorectal cancer Once a ... to a distant site it becomes much harder to treat. ... Williams, at Vanderbilt University School of Medicine, Nashville, has now ... progression to this dangerous state, leading them to suggest that ...
... multi-disciplinary expert panel, convened by the American Dental Association ... month containing clinical recommendations that sugar-free chewing gum, lozenges ... and a prescription varnish with chlorhexidine and thymol could ... to a comprehensive cavity prevention program which includes ...
Cached Medicine News:Health News:September/October 2011 Annals of Family Medicine Tip Sheet 2Health News:September/October 2011 Annals of Family Medicine Tip Sheet 3Health News:September/October 2011 Annals of Family Medicine Tip Sheet 4Health News:September/October 2011 Annals of Family Medicine Tip Sheet 5Health News:September/October 2011 Annals of Family Medicine Tip Sheet 6Health News:September/October 2011 Annals of Family Medicine Tip Sheet 7Health News:September/October 2011 Annals of Family Medicine Tip Sheet 8Health News:Reduce health care spending in socially and fiscally responsible manner, ACP to Congress 2Health News:Women With BRCA Mutations Get Cancer Diagnosis Earlier Than Before 2Health News:Women With BRCA Mutations Get Cancer Diagnosis Earlier Than Before 3Health News:ASGE recognizes 21 endoscopy units for quality and safety 2Health News:ASGE recognizes 21 endoscopy units for quality and safety 3Health News:JCI online early table of contents: Sept. 12, 2011 2Health News:JCI online early table of contents: Sept. 12, 2011 3Health News:JCI online early table of contents: Sept. 12, 2011 4Health News:JCI online early table of contents: Sept. 12, 2011 5Health News:JCI online early table of contents: Sept. 12, 2011 6Health News:JCI online early table of contents: Sept. 12, 2011 7Health News:JCI online early table of contents: Sept. 12, 2011 8Health News:Sugar-free polyol gum, lozenges, hard candy; Nonfluoride varnishes help prevent cavities 2Health News:Sugar-free polyol gum, lozenges, hard candy; Nonfluoride varnishes help prevent cavities 3
... potent glucocorticoid produced by the human ... is bound with high affinity to ... loosely bound to albumin. Cortisol acts ... in numerous physiologic systems, including immune ...
... or somatomedin C) is a 7.6 kDa peptide ... a potent mitogen of cellular proliferation, exerting its ... the circulation, IGF-I is bound to IGF-binding proteins ... IGF-I by modulating the interaction of IGF-I with ...
... somatomedin C) is a 7.6 kDa peptide produced ... potent mitogen of cellular proliferation, exerting its actions ... circulation, IGF-I is bound to IGF-binding proteins (IGFBPs), ... by modulating the interaction of IGF-I with the ...
Urovac bladder evacuator with adaptor...
Medicine Products: